Bruker
BRKR
#2321
Rank
$8.00 B
Marketcap
$52.67
Share price
2.77%
Change (1 day)
-12.94%
Change (1 year)
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis.

P/E ratio for Bruker (BRKR)

P/E ratio as of January 2026 (TTM): -327

According to Bruker's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -326.875. At the end of 2024 the company had a P/E ratio of 76.9.

P/E ratio history for Bruker from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202476.9207.41%
202325.0-26.15%
202233.9-25.23%
202145.3-12.56%
202051.832.44%
201939.154.39%
201825.4-62.1%
201766.9209.62%
201621.6-43.6%
201538.3-31.05%
201455.640.11%
201339.727.02%
201231.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
PerkinElmer
PKI
15.0-104.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
35.7-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Waters Corporation
WAT
36.7-111.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-13.4-95.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
32.0-109.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
32.6-109.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Accelerate Diagnostics
AXDX
-0.0192-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
48.3-114.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ametek
AME
33.5-110.25%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
43.5-113.32%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.